Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery

ConclusionIn this study, a novel 6-gene signature with robust predictive ability on post-operative BCR was constructed and 4 genes (SMIM22, NRG2, NINL and TPCN2) in the 6-gene signature were not reported to be associated with prostate cancer.

http://link.springer.com/10.1007/s12094-018-02029-z

Source: Clinical and Translational Oncology - January 12, 2019 Category: Cancer & Oncology Source Type: research